For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…

Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy Again…

Blog
CBO likely overestimates effects of Medicaid reforms
Yesterday, the Congressional Budget Office (CBO) released its estimates of the costs, both financial and in coverage, of the One Big Beautiful Bill Act…
Search Posts
Study
Evaluating Telehealth
Executive Summary Why Did We Write This Report Telehealth—the use of remote audio and/or video technologies to provide health care services—has been promoted as…
News Release
Report: Telehealth flexibility deadline looms, but Congress needs better information to decide
Congress is poised to consider proposals that permanently or temporarily extend flexibilities for telehealth services enacted during the COVID-19 pandemic that are set to expire…
Blog
This week in ridiculous regulations: Human subjects and food paper
Republicans called Puerto Rico a “floating island of garbage” as a voter outreach tactic. Democrats got upset that a newspaper that generally supports Democrats didn’t endorse…
The Washington Post
What Trump winning the election could mean for the CDC
The Washington Post cites CEI expert Joel Zinberg on the changing face of the CDC and what does (and doesn’t) belong in the agency: “Many…
CSPAN
VIDEO: Dr. Joel Zinberg joins CSPAN to discuss health care proposals from presidential candidates
Click here to read more.
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …